-
AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment
18 Apr 2024 18:56 GMT
… 26th. Analysts are forecasting earnings per share ("EPS… to worry, hence Q1 2024 earnings should be straightforward to interpret … in a partnership with Daiichi Sankyo to develop ADC's … deliver a set of earnings that surprises, and ultimately …
-
JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?
15 Apr 2024 23:38 GMT
… see if its first-quarter earnings will shake up the Pharmaceutical … company’s adjusted net earnings and net earnings per share from continuing … industry: GSK PLC ADR (GSK), Daiichi Sankyo Company, Limited (DSNKY), and Taro …
-
GLP-1 surge, oncology stars to power industry's earnings growth over the next 18 months: Moody's
15 Mar 2024 16:37 GMT
… the industry’s overall earnings performance has been … Squibb, Roche, AstraZeneca and Daiichi Sankyo.
Beyond 12 to 18 months … the potential to affect industry earnings, according to Moody… in 2026.
Another potential earnings pressure is more patent …
-
Daiichi Sankyo Again Raises Enhertu Sales Forecast Driven by Non-US Growth
01 Feb 2024 13:23 GMT
… to its third quarter earnings report for the fiscal … October 2023.
According to Daiichi Sankyo’s presentation on Wednesday … business into consideration, Daiichi Sankyo reported a total revenue … As for pipeline updates, Daiichi Sankyo and partner AstraZeneca are …
-
Merck still on the hunt for billion-dollar deals, citing Prometheus and Daiichi Sankyo as examples
01 Feb 2024 16:34 GMT
Merck is still in pursuit of deals of a similar size and scope to the company’s acquisitions of Prometheus Biosciences and Acceleron, and is willing to pay up to $15 billion.
It’s also still considering smaller deals and …
-
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript
28 Feb 2024 13:53 GMT
… (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript February 27, 2024 … Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $- … s Fourth Quarter 2023 Earnings Conference Call. At … to our collaboration with Daiichi Sankyo Europe, which marked the …
-
AstraZeneca PLC (NASDAQ:AZN) Q4 2023 Earnings Call Transcript
09 Feb 2024 16:26 GMT
… NASDAQ:AZN) Q4 2023 Earnings Call Transcript February 8, … 2024
AstraZeneca PLC misses on earnings expectations. Reported EPS is … with this collaboration with Daiichi Sankyo, that you know very … sales in regions where Daiichi Sankyo books product sales. …
-
AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript
08 Feb 2024 23:17 GMT
… (AZN -4.55%)
Q4 2023 Earnings Call
Feb 08, 2024, 6 … started with this collaboration with Daiichi Sankyo, that you know very … payments including milestone payments to Daiichi Sankyo. For this year, we … Analyst
More AZN analysis
All earnings call transcripts
-
Merck & Co., Inc. (NYSE:MRK) Q4 2023 Earnings Call Transcript
02 Feb 2024 16:42 GMT
… (NYSE:MRK) Q4 2023 Earnings Call Transcript February 1, 2024 … ; Co. Q4 Sales and Earnings Conference Call. [Operator Instructions] … slides, along with the earnings release, today’s prepared … to our collaboration with Daiichi Sankyo. Excluding this charge, …
-
Merck (MRK) Q4 2023 Earnings Call Transcript
01 Feb 2024 20:11 GMT
… ; Company Q4 sales and earnings conference call. At this … These slides, along with the earnings release, today's … related to our collaboration with Daiichi Sankyo. Excluding this charge, … ; Company Q4 sales and earnings conference call. That concludes …